Die AWMF-Leitlinie Schimmelpilzexposition in Innenräumen: Kernbotschaften DOI
Julia Hurraß,

Gerhard A. Wiesmüller

Allergo Journal, Journal Year: 2024, Volume and Issue: 33(4), P. 24 - 27

Published: June 1, 2024

Correspondence DOI

Gerhard A. Wiesmüller

Deutsches Ärzteblatt international, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 5, 2025

Citations

0

Allergen-specific immunotherapy for mold allergies DOI Creative Commons
Randolf Brehler,

Uta Rabe

Allergo Journal International, Journal Year: 2024, Volume and Issue: 33(4), P. 101 - 105

Published: April 23, 2024

Abstract Molds are ubiquitous in our environment and considered by the population to be most important indoor pollutant problem [1]. The current 2023 update AWMF mold guideline [1] is intended allay or channel fears provide assistance for a sensible diagnosis treatment decision. detection of an IgE-mediated allergy implies allergists Allergen immunotherapy (AIT) as established option. However, compared well-validated AIT with pollen house dust mites, decision use extracts must weighed more heavily between benefits risks. Spores Alternaria alternata found high concentrations outdoor air. Due allergenic potential small size spores, often leads bronchial asthma, especially children. effectiveness has been tested several studies; other molds, those from environment, efficacy applicability very limited. In terms differential diagnosis, it borne mind that molds can not only cause common allergic reactions but also responsible bronchopulmonary mycoses/aspergillosis (ABPA), Aspergillus bronchitis, exogenous alveolitis (EAA), invasive aspergillosis, mycoses rhinosinusitis. Very concentrations, which occur particularly workplaces, result toxic effects (“organic syndrome”); held mucous membrane irritation, odor mood disorders

Language: Английский

Citations

2

The German guideline on medical clinical diagnostics for indoor mold exposure: key messages DOI Creative Commons
Julia Hurraß,

Gerhard A. Wiesmüller

Allergo Journal International, Journal Year: 2024, Volume and Issue: 33(4), P. 106 - 109

Published: May 7, 2024

Abstract The AWMF S2k guideline “Medical clinical diagnostics for indoor mold exposure” was introduced in 2016. is based on a standardized procedure of the including systematic literature search involving several medical disciplines. expert group has updated this accordance with specifications. For purpose, new Medline carried out current version up to June 2022 additional terms. results were evaluated and further narrowed down by means abstract screening and, where applicable, evidence-based evaluation full texts. Medical guidelines related topics also taken into account. available since October 2023. This intended close existing knowledge gap rational efficient contamination provides 26 core statements recommendations, which are presented detail.

Language: Английский

Citations

0

Wie wirken sich Mykotoxine, Zellwandbestandteile, Enzyme, andere Schimmelbestandteile und Schimmelmetabolite auf die gesundheitliche Befindlichkeit aus? DOI
Julia Hurraß,

Rabea Teubel,

Guido Fischer

et al.

Allergo Journal, Journal Year: 2024, Volume and Issue: 33(4), P. 43 - 51

Published: June 1, 2024

Citations

0

Allergenspezifische Immuntherapie bei Schimmelpilzallergien DOI
Randolf Brehler,

Uta Rabe

Allergo Journal, Journal Year: 2024, Volume and Issue: 33(4), P. 16 - 23

Published: June 1, 2024

Citations

0

Die AWMF-Leitlinie Schimmelpilzexposition in Innenräumen: Kernbotschaften DOI
Julia Hurraß,

Gerhard A. Wiesmüller

Allergo Journal, Journal Year: 2024, Volume and Issue: 33(4), P. 24 - 27

Published: June 1, 2024

Citations

0